Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial.

ABSTRACT:

SUBMITTER: Kliewer KL 

PROVIDER: S-EPMC10529697 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature